BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21921872)

  • 1. Adjunctive antipsychotics for major depression.
    Med Lett Drugs Ther; 2011 Sep; 53(1373):74-5. PubMed ID: 21921872
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of atypical antipsychotics in bipolar disorder.
    Ehret MJ; Levin GM
    Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Finkel S
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y; Guo Z; Kalsekar I; Forbes RA; Hebden T; Thase ME
    Int Clin Psychopharmacol; 2013 Mar; 28(2):87-90. PubMed ID: 23262644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 11. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
    Chen J; Gao K; Kemp DE
    Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of atypical antipsychotics after traumatic brain injury.
    Elovic EP; Jasey NN; Eisenberg ME
    J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression.
    Jing Y; Kalsekar I; Curkendall SM; Carls GS; Bagalman E; Forbes RA; Hebden T; Thase ME
    Clin Ther; 2011 Sep; 33(9):1246-57. PubMed ID: 21840058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
    Erbe S; Gutwinski S; Bschor T
    Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Datapoints: The ups and downs of dosing second-generation antipsychotics.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2007 Jan; 58(1):11. PubMed ID: 17215406
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
    Philip NS; Carpenter LL; Tyrka AR; Price LH
    J Psychiatr Pract; 2008 Jan; 14(1):34-44. PubMed ID: 18212601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of atypical antipsychotics in mood disorders.
    Weizman R; Weizman A
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.